VTYX•benzinga•
HC Wainwright & Co. Maintains Buy on Ventyx Biosciences, Raises Price Target to $50
Summary
No summary available.
Original Article
Read the full article from the original source for complete details and context.
Read Full ArticleArticle published on September 13, 2022 by benzinga